Expressions of maspin, P53 and Skp2 in colorectal tumors and their clinicopathological significance

Chinese Journal of Cancer Research

Volumn 21, Issue 2, 2009, Pages 147-153

  Ni, Jiang Tao ^a   Yi, Yong Fen ^a   Shi, Hai Peng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Immunohistochemistry; Maspin; P53; Skp2

Indexed keywords

MASPIN; PROTEIN P53; S PHASE KINASE ASSOCIATED PROTEIN 2;

ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; COLORECTAL ADENOCARCINOMA; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; LYMPH NODE METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 67449156435     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-009-0147-z     Document Type: Article

References (34)

1. Yatabe Y, Mitsudomi T and Takahashi T. Maspin expression in normal lung and non-small cell lung cancers: Cellular property-associated expression under the control of promoter DNA methylation [J]. Oncogene 2004; 23: 4041-4049.
2. Maass N, Hojo T, Zhang M, et al. Maspin-a novel protease inhibitor with tumor-suppressing activity in breast cancer [J]. Acta Oncol 2000; 39: 931-934.
3. Zhang W, Shi HY, Zhang M. Maspin overpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins [J]. BMC Cancer 2005; 5: 50.
4. Liu J, Yin S, Reddy N, et al. Bax mediates the apoptosis-sensitizing effect of maspin [J]. Cancer Res 2004; 64: 1703-1711.
5. Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells [J]. Cancer Biol Ther 2003; 2: 389-403.
6. Ngamkitidechakul C, Warejcka DJ, Burke JM, et al. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule [J]. J Biol Chem 2003; 278: 31796-31806.
7. Maass N, Hojo T, Rosel F, et al. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis [J]. Clin Biochem 2001; 34: 303-307.
8. Machtens S, Serth J, Bokemeyer C, et al. Expression of the p53 and Maspin protein in primary prostate cancer: Correlation with clinical feature [J]. Int J Cancer 2001; 95: 337-342.
9. Maass N, Hojo T, Ueding M, et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers [J]. Clin Cancer Res 2001; 7: 812-817.
10. Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma [J]. Clin Cancer Res 2002; 8: 2924-2932.
11. Hirai K, Koizumi K, Haraguchi S, et al. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer[J]. Ann Thorac Surg 2005; 79: 248-253.
12. Ito Y, Yoshida H, Tomoda C, et al. Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma [J]. Thyroid 2004; 14: 13-18.
13. Sugimoto S, Maass N, Takimoto Y, et al. Expression and regulation of tumor suppressor gene maspin in human bladder cancer [J]. Cancer Lett 2004; 203: 209-215.
14. Terashima M, Maesawa C, Oyama K, et al. Gene expression profiles in human gastric cancer: Expression of maspin correlates with lymph node metastasis [J]. Br J Cancer 2005; 92: 1130-1136.
15. Doo-Young Lee, Chang-Soo Park, Hyung-Seok Kim, et al. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications [J]. Appl Immunohistochem Mol Morphol 2008; 16: 14-15.
16. Sheng S, Pemberton PA, Sager R. Production, purification, and characterization of recombinant maspin proteins [J]. J Biol Chem 1994; 269: 30988-30993.
17. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells [J]. Science 1994; 263: 526-529.
18. Seftor RE, Seftor EA, Sheng S, et al. Maspin suppresses the invasive phenotype of human breast carcinoma [J]. Cancer Res 1998; 58: 5681-5685.
19. Umekita Y, Hiipakka RA, Liao S. Rat and human maspins: Structures, metastatic suppressor activity and mutation in prostate cancer cells [J]. Cancer Lett 1997; 113: 87-93.
20. Xia W, Lau YK, Hu MC, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma [J]. Oncogene 2000; 19: 2398-2403.
21. Song SY, Lee SK, Kim DH, et al. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density [J]. Dig Dis Sci 2002; 47: 1831-1835.
22. Boltze C. Loss of maspin is a helpful prognosticator in colorectal cancer: A tissue microarray analysis [J]. Pathol Res Pract 2005; 200: 783-790.
23. Dengfeng Cao, Qian Zhang, Lee Shun-Fune Wu, et al. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: Tissue microarray analysis of 223 surgically resected cases [J]. Mod Pathol 2007; 20: 570-578.
24. Zou Z, Gao C, Nagaich AK, et al. P53 regulates the expression of the tumor suppressor gene maspin [J]. J Biol Chem 2000; 275: 6051-6054.
25. Ito R, Nakayama H, Yoshida K, et al. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality [J]. Oncol Rep 2004; 12: 985-990.
26. Machtens S, Serth J, Bokemeyer C, et al. Expression of the p53 and maspin protein in primary prostate cancer: Correlation with clinical features [J]. Int J Cancer 2001; 95: 337-342.
27. Boltze C, Schneider-Stock R, Meyer F, et al. Maspin in thyroid cancer: its relationship with p53 and clinical outcome [J]. Oncol Rep 2003; 10:1783-1787.
28. Umekita Y, Ohi Y, Sagara Y, et al. Expression of maspin predicts poor prognosis in breast-cancer patients [J]. Int J Cancer 2002; 100: 452-455.
29. Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased levels of the cell-cycle inhibitor p27 Kip1 inhibitor protein: Prognostic implications in primary breast cancer [J]. Nat Med 1997; 3:227-230.
30. Esposito V, Baldi A, De Luca A, et al. Prognostic role of the cyclin dependent kinase inhibitor p27 in non-small lung cancer [J]. Cancer Res 1997; 57: 3382-3385.
31. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas [J]. Nat Med 1997; 3:231-234.
32. Mori M, Mimori K, Shiraidhi T, et al. p27 expression and gastric carcinoma [J]. Nat Med 1997; 36: 593.
33. Guo Y, Sklar GN, Borkowsky A, et al. Loss of cyclin-dependent kinase inhibitor p27 Kip1 in human prostate cancer correlates with tumor grade [J]. Clin Cancer Res 1997; 3:2269-2274.
34. Li JQ, Wu F, Masaki T, et al. Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors [J]. Int J Oncol 2004; 25: 87-95.